Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Urinary Bladder Neoplasms 1 Surgery 1 Sarcoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Ductal Adenocarcinoma 1 Multiple Myeloma 1 Medulloblastoma 1 Lung Neoplasms 1 Liposarcoma 1 Leiomyosarcoma 1 HER2-positive Breast Cancer 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Intraductal, Noninfiltrating 1

Interventions

pembrolizumab 2 Doxorubicin 2 selinexor 1 ribociclib 1 pazopanib 1 palbociclib 1 mirdametinib 1 abemaciclib 1 X-Rays 1 Surgical Procedures, Operative 1 Specimen Handling 1 Radiotherapy 1 Radiation 1 Proton Therapy 1 Neoadjuvant Therapy 1 Magnetic Resonance Spectroscopy 1 Ifosfamide 1 Histamine H2 Antagonists 1 Famotidine 1 Everolimus 1 Angptl4 protein, mouse 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Liposarcoma × Neoadjuvant Therapy × 30 days × Clear all

NCT04031677 2026-05-22

STRASS2

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Recruiting

Leiomyosarcoma, Liposarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡